280 related articles for article (PubMed ID: 27979915)
1. Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients.
Portnow J; Synold TW; Badie B; Tirughana R; Lacey SF; D'Apuzzo M; Metz MZ; Najbauer J; Bedell V; Vo T; Gutova M; Frankel P; Chen M; Aboody KS
Clin Cancer Res; 2017 Jun; 23(12):2951-2960. PubMed ID: 27979915
[No Abstract] [Full Text] [Related]
2. Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients.
Portnow J; Badie B; Suzette Blanchard M; Kilpatrick J; Tirughana R; Metz M; Mi S; Tran V; Ressler J; D'Apuzzo M; Aboody KS; Synold TW
Cancer Gene Ther; 2021 Apr; 28(3-4):294-306. PubMed ID: 32895489
[TBL] [Abstract][Full Text] [Related]
3. Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.
Aboody KS; Najbauer J; Metz MZ; D'Apuzzo M; Gutova M; Annala AJ; Synold TW; Couture LA; Blanchard S; Moats RA; Garcia E; Aramburo S; Valenzuela VV; Frank RT; Barish ME; Brown CE; Kim SU; Badie B; Portnow J
Sci Transl Med; 2013 May; 5(184):184ra59. PubMed ID: 23658244
[TBL] [Abstract][Full Text] [Related]
4. VP22 and cytosine deaminase fusion gene modified tissue-engineered neural stem cells for glioma therapy.
Jin G; Zhou Y; Chai Q; Zhu G; Xu F; Liu F
J Cancer Res Clin Oncol; 2013 Mar; 139(3):475-83. PubMed ID: 23180018
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of genetically modified human neural stem cells encoding cytosine deaminase on experimental glioma.
Kim JH; Kim JY; Kim SU; Cho KG
Biochem Biophys Res Commun; 2012 Jan; 417(1):534-40. PubMed ID: 22177952
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
[TBL] [Abstract][Full Text] [Related]
7. Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma.
Ito S; Natsume A; Shimato S; Ohno M; Kato T; Chansakul P; Wakabayashi T; Kim SU
Cancer Gene Ther; 2010 May; 17(5):299-306. PubMed ID: 19893595
[TBL] [Abstract][Full Text] [Related]
8. Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.
Kang W; Seol HJ; Seong DH; Kim J; Kim Y; Kim SU; Nam DH; Joo KM
Oncol Rep; 2013 Sep; 30(3):1101-6. PubMed ID: 23828015
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment of tumor-tropic human neural stem cells containing the CD suicide gene effectively targets brain tumors provoking a mild immune response.
Lee SJ; Kim Y; Jo MY; Kim HS; Jin Y; Kim SU; Jin J; Joo KM; Nam DH
Oncol Rep; 2011 Jan; 25(1):63-8. PubMed ID: 21109958
[TBL] [Abstract][Full Text] [Related]
10. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.
Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS
Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128
[TBL] [Abstract][Full Text] [Related]
11. Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models.
Yi BR; Hwang KA; Aboody KS; Jeung EB; Kim SU; Choi KC
Stem Cell Res; 2014 Jan; 12(1):36-48. PubMed ID: 24141111
[TBL] [Abstract][Full Text] [Related]
12. Anti-proliferative Effect of Engineered Neural Stem Cells Expressing Cytosine Deaminase and Interferon-β against Lymph Node-Derived Metastatic Colorectal Adenocarcinoma in Cellular and Xenograft Mouse Models.
Park GT; Kim SU; Choi KC
Cancer Res Treat; 2017 Jan; 49(1):79-91. PubMed ID: 27188205
[TBL] [Abstract][Full Text] [Related]
13. Targeted Treatment of Experimental Spinal Cord Glioma With Dual Gene-Engineered Human Neural Stem Cells.
Ropper AE; Zeng X; Haragopal H; Anderson JE; Aljuboori Z; Han I; Abd-El-Barr M; Lee HJ; Sidman RL; Snyder EY; Viapiano MS; Kim SU; Chi JH; Teng YD
Neurosurgery; 2016 Sep; 79(3):481-91. PubMed ID: 26671631
[TBL] [Abstract][Full Text] [Related]
14. Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use.
Metz MZ; Gutova M; Lacey SF; Abramyants Y; Vo T; Gilchrist M; Tirughana R; Ghoda LY; Barish ME; Brown CE; Najbauer J; Potter PM; Portnow J; Synold TW; Aboody KS
Stem Cells Transl Med; 2013 Dec; 2(12):983-92. PubMed ID: 24167321
[TBL] [Abstract][Full Text] [Related]
15. Antithyroid cancer effects of human neural stem cells expressing therapeutic genes on anaplastic thyroid cancer cells.
Shin HJ; Hwang KA; Go RE; Kim SU; Choi KC
J Cell Biochem; 2020 Feb; 121(2):1586-1598. PubMed ID: 31512776
[TBL] [Abstract][Full Text] [Related]
16. Additional effects of engineered stem cells expressing a therapeutic gene and interferon-β in a xenograft mouse model of endometrial cancer.
Yi BR; Kim SU; Choi KC
Int J Oncol; 2015 Jul; 47(1):171-8. PubMed ID: 25963746
[TBL] [Abstract][Full Text] [Related]
17. Neural stem cell-based dual suicide gene delivery for metastatic brain tumors.
Wang C; Natsume A; Lee HJ; Motomura K; Nishimira Y; Ohno M; Ito M; Kinjo S; Momota H; Iwami K; Ohka F; Wakabayashi T; Kim SU
Cancer Gene Ther; 2012 Nov; 19(11):796-801. PubMed ID: 23018623
[TBL] [Abstract][Full Text] [Related]
18. Molecular Analyses Support the Safety and Activity of Retroviral Replicating Vector Toca 511 in Patients.
Hogan DJ; Zhu JJ; Diago OR; Gammon D; Haghighi A; Lu G; Das A; Gruber HE; Jolly DJ; Ostertag D
Clin Cancer Res; 2018 Oct; 24(19):4680-4693. PubMed ID: 29945998
[No Abstract] [Full Text] [Related]
19. Selective delivery of a therapeutic gene for treatment of head and neck squamous cell carcinoma using human neural stem cells.
Kwon SK; Kim SU; Song JJ; Cho CG; Park SW
Clin Exp Otorhinolaryngol; 2013 Sep; 6(3):176-83. PubMed ID: 24069522
[TBL] [Abstract][Full Text] [Related]
20. Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases.
Joo KM; Park IH; Shin JY; Jin J; Kang BG; Kim MH; Lee SJ; Jo MY; Kim SU; Nam DH
Mol Ther; 2009 Mar; 17(3):570-5. PubMed ID: 19127251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]